Summary of recommendations
| Problem | Recommendations |
| Screening tools | AUDIT |
| PAWSS | |
| Ancillary services to consider | Social work |
| Addiction Medicine | |
| Psychiatry/Psychiatry Nursing | |
| Patients to receive empiric prophylaxis (in appropriate clinical context) | History of complicated alcohol withdrawal (delirium tremens±seizures) |
| Multiple prior episodes or long duration of alcohol use | |
| Comorbid medical or surgical illness (including TBI) | |
| Age >65 years | |
| Autonomic hyperactivity on presentation | |
| Physiologic dependence on benzodiazepines or barbiturates | |
| Elevated alcohol level, MCV, or AST:ALT ratio on presentation | |
| Method of surveillance | mMINDS |
| Medications for primary prevention | Benzodiazepines |
| Phenobarbital | |
| Alternative medications for prevention | Clonidine |
| Gabapentin | |
| Dexmedetomidine (adjunct to benzodiazepines) | |
| Propofol (adjunct to benzodiazepines) |
ALT, alanine transaminase; AST, aspartate transaminase; AUDIT, Alcohol Use Disorders Identification Test; MCV, mean corpuscular volume; mMINDS, modified Minnesota Detoxification Scale; PAWSS, Prediction of Alcohol Withdrawal Severity Scale; TBI, traumatic brain injury.